Nasal drug delivery - possibilities, problems and solutions

被引:752
作者
Illum, L
机构
[1] Drug Delivery & Clin Res Ctr Ltd, W Pharmaceut Serv, Albert Einstein Ctr, Nottingham, England
[2] ID Entity, Nottingham NG7 1BA, England
关键词
D O I
10.1016/S0168-3659(02)00363-2
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This paper discusses the problems associated with nasal drug delivery and how it is possible, sometimes by means of quite simple concepts, to improve transport across the nasal membrane. In this way it is feasible to deliver efficiently challenging drugs such as small polar molecules, peptides and proteins and even the large proteins and polysaccharides used in vaccines or DNA plasmids exploited for DNA vaccines. The transport of drugs from the nasal cavity directly to the brain is also described and examples of studies in man, where this has been shown to be feasible, are discussed. Recent results from Phase I/II studies in man with a novel nasal chitosan vaccine delivery system are also described. Finally, the author's thoughts about the future for nasal drug delivery are also depicted. (C) 2002 Published by Elsevier Science B.V.
引用
收藏
页码:187 / 198
页数:12
相关论文
共 46 条
[1]  
[Anonymous], DRUG DELIVERY ISSUES
[2]   EFFECT OF CHITOSAN ON THE PERMEABILITY OF MONOLAYERS OF INTESTINAL EPITHELIAL-CELLS (CACO-2) [J].
ARTURSSON, P ;
LINDMARK, T ;
DAVIS, SS ;
ILLUM, L .
PHARMACEUTICAL RESEARCH, 1994, 11 (09) :1358-1361
[3]  
BEHL C, 2000, MAN FOR M NAS DRUG D
[4]   The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children [J].
Belshe, RB ;
Mendelman, PM ;
Treanor, J ;
King, J ;
Gruber, WC ;
Piedra, P ;
Bernstein, DI ;
Hayden, FG ;
Kotloff, K ;
Zangwill, K ;
Iacuzio, D ;
Wolff, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) :1405-1412
[5]   Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides [J].
Cano, F ;
Plotnicky-Gilquin, H ;
Nguyen, TN ;
Liljeqvist, S ;
Samuelson, P ;
Bonnefoy, JY ;
Ståhl, S ;
Robert, A .
VACCINE, 2000, 18 (24) :2743-2752
[6]   Transfer of dopamine in the olfactory pathway following nasal administration in mice [J].
Dahlin, M ;
Bergman, U ;
Jansson, B ;
Bjork, E ;
Brittebo, E .
PHARMACEUTICAL RESEARCH, 2000, 17 (06) :737-742
[7]   Intranasal angiotensin II directly influences central nervous regulation of blood pressure [J].
Derad, I ;
Willeke, K ;
Pietrowsky, R ;
Born, J ;
Fehm, HL .
AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (08) :971-977
[8]   Effect of chitosan on epithelial permeability and structure [J].
Dodane, V ;
Khan, MA ;
Merwin, JR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 182 (01) :21-32
[9]   Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology? [J].
Fehm, HL ;
Perras, B ;
Smolnik, R ;
Kern, W ;
Born, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 405 (1-3) :43-54
[10]   The melanocortin melanocyte-stimulating hormone/adrenocorticotropin4-10 decreases body fat in humans [J].
Fehm, HL ;
Smolnik, R ;
Kern, W ;
McGregor, GP ;
Bickel, U ;
Born, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1144-1148